CITRASATE C2150 SOLUTION

Country: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

POTASSIUM CHLORIDE; SODIUM CHLORIDE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; DEXTROSE; CITRIC ACID; SODIUM ACETATE

Disponibbli minn:

CHIEF MEDICAL SUPPLIES LTD

Kodiċi ATC:

B05ZA

INN (Isem Internazzjonali):

HEMODIALYTICS, CONCENTRATES

Dożaġġ:

6.71G; 263G; 7.47G; 2.14G; 49.5G; 6.91G; 1.11G

Għamla farmaċewtika:

SOLUTION

Kompożizzjoni:

POTASSIUM CHLORIDE 6.71G; SODIUM CHLORIDE 263G; CALCIUM CHLORIDE 7.47G; MAGNESIUM CHLORIDE 2.14G; DEXTROSE 49.5G; CITRIC ACID 6.91G; SODIUM ACETATE 1.11G

Rotta amministrattiva:

HAEMODIALYSIS

Unitajiet fil-pakkett:

4.5L

Tip ta 'preskrizzjoni:

Ethical

Żona terapewtika:

HEMODIALYSIS SOLUTION

Sommarju tal-prodott:

Active ingredient group (AIG) number: 0752576007; AHFS:

L-istatus ta 'awtorizzazzjoni:

MARKETED

Data ta 'l-awtorizzazzjoni:

2013-02-21

Karatteristiċi tal-prodott

Page 1 of 7
PRODUCT MONOGRAPH
CITRASATE
® C2150
Haemodialysis Solution, BP
Sodium Chloride
263 g / L
Potassium Chloride
6.71 g / L
Calcium Chloride
7.47 g / L
Magnesium Chloride
2.14 g / L
Citric Acid
6.91 g / L
Sodium Acetate
1.11 g / L
Glucose Monohydrate
49.5 g / L
CHIEF MEDICAL SUPPLIES LTD.
DATE OF REVISION:
411-19
th
Street S.E.
January 14, 2021
Calgary Alberta T2E 6J7
CONTROL NO.: 242794
Page 2 of 7
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION………………………...
3
SUMMARY PRODUCT
INFORMATION……………………………………...
3
INDICATIONS AND CLINICAL
USE…………………………………………
3
CONTRAINDICATIONS……………………………………………………….
3
WARNINGS AND
PRECAUTIONS……………………………………………
4
ADVERSE
REACTIONS………………………………………………………..
4
DRUG
INTERACTIONS………………………………………………………...
4
DOSAGE AND
ADMINISTRATION…………………………………………..
4
OVERDOSAGE………………………………………………………………….
5
ACTIONS AND CLINCAL PHARMACOLOGY………………………………
6
STORAGE AND
STABILITY…………………………………………………...
6
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..
6
REFERENCES……………………………………………………………………
6
MORE
INFORMATION…………………………………………………………
7
Page 3 of 7
CITRASATE
® C2150
Haemodialysis Solution, BP
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF ADMINISTRATION
DOSAGE FORM / STRENGTH
CLINICALLY RELEVANT NON-
MEDICINAL INGREDIENTS
Hemodialysis
Concentrated solution
Sodium Chloride 263 g / L
Potassium Chloride
6.71 g / L
Calcium Chloride 7.47 g / L
Magnesium Chloride 2.14 g / L
Citric Acid 6.91 g / L
Sodium Acetate 1.11 g / L
Glucose Monohydrate 49.5 g / L
None
INDICATIONS AND CLINICAL USE
Citrasate C